Scientists in South Korea have made a breakthrough in colorectal cancer research, the second-most common cause of cancer ...

A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases40% increase in output to ...

Using bacteria to attack cancer cells is not a new idea, but the Waterloo researchers have engineered a solution to one of the biggest challenges inherent to the method.

The research reveals something fundamental about cancer. It’s not a sudden event that instantly produces a tumour. Instead, cancer develops through a slow, multi-step process with detectable warning ...

At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions  SAN DIEGO, Feb. 26, 2026 ...

Add Yahoo as a preferred source to see more of our stories on Google. With input from oncologists, surgeons and specialists, here’s a closer look at the breakthroughs making headlines in 2025, what ...

The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).

Discover how India's unique resources could lead to groundbreaking advancements in global cancer care and research.

Cancer survival rates are on the rise, according to the American Cancer Society's latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, ...

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.